Skip to main content
Top
Published in: American Journal of Clinical Dermatology 2/2000

01-03-2000 | Disease Management

Management of Seborrheic Dermatitis and Pityriasis Versicolor

Author: Dr Jan Faergemann

Published in: American Journal of Clinical Dermatology | Issue 2/2000

Login to get access

Abstract

Pityriasis (tinea) versicolor and seborrheic dermatitis are two very common skin diseases. Pityriasis versicolor is a chronic superficial fungal disease usually located on the upper trunk, neck, or upper arms. In pityriasis versicolor, the lipophilic yeast Malassezia (also know as Pityrosporum ovale or P. orbiculare) changes from the blastospore form to the mycelial form under the influence of predisposing factors. The most important exogenous factors are high temperatures and a high relative humidity which probably explain why pityriasis versicolor is more common in the tropics. The most important endogenous factors are greasy skin, hyperhidrosis, hereditary factors, corticosteroid treatment and immunodeficiency. There are many ways of treating pityriasis versicolor topically. Options include propylene glycol, ketoconazole shampoo, zinc pyrithione shampoo, ciclopiroxamine, selenium sulfide, and topical antifungals. In difficult cases, short term treatment with fluconazole or itraconazole is effective and well tolerated. To avoid recurrence a prophylactic treatment regimen is mandatory.
Seborrheic dermatitis is characterized by red scaly lesions predominantly located on the scalp, face and upper trunk. There are now many studies indicating that Malassezia plays an important role in this condition. Even a normal number of Malassezia will start an inflammatory reaction. Mild corticosteroids are effective in the treatment of seborrheic dermatitis. However, the disease recurs quickly, often within just a few days. Antifungal therapy is effective in the treatment of seborrheic dermatitis and, because it reduces the number of Malassezia, the time to recurrence is increased compared with treatment with corticosteroids. Antifungal therapy should be the primary treatment of this disease.
Literature
1.
go back to reference Gordon M.A. The lipophilic microflora of the skin. Mycologia 1951; 43: 524–534CrossRef Gordon M.A. The lipophilic microflora of the skin. Mycologia 1951; 43: 524–534CrossRef
2.
go back to reference Roberts S.O.B. Pityrosporum orbiculare: incidence and distribution on clinical normal skin. Br J Dermatol 1969; 81: 264–269PubMedCrossRef Roberts S.O.B. Pityrosporum orbiculare: incidence and distribution on clinical normal skin. Br J Dermatol 1969; 81: 264–269PubMedCrossRef
3.
go back to reference Faergemann J, Aly R, Maibach HI. Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin. Acta Derm Venereol (Stockh) 983; 63: 346–8 Faergemann J, Aly R, Maibach HI. Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin. Acta Derm Venereol (Stockh) 983; 63: 346–8
4.
go back to reference Faergemann J., Fredriksson T. Age incidence of Pityrosporum orbiculare on human skin. Acta Derm Venereol (Stockh) 1980; 60: 531–533 Faergemann J., Fredriksson T. Age incidence of Pityrosporum orbiculare on human skin. Acta Derm Venereol (Stockh) 1980; 60: 531–533
5.
go back to reference Gueho E., Midgley G., Guillot J. The genus Malassezia with description of four new species. Antonie v Leuwenhoek 1996; 69: 337–355CrossRef Gueho E., Midgley G., Guillot J. The genus Malassezia with description of four new species. Antonie v Leuwenhoek 1996; 69: 337–355CrossRef
6.
go back to reference Guillot J., Guého E., Lesourd M., et al. Identification of Malassezia species — a practical approach. J Mycol Méd 1996; 6: 103–110 Guillot J., Guého E., Lesourd M., et al. Identification of Malassezia species — a practical approach. J Mycol Méd 1996; 6: 103–110
7.
go back to reference Faergemann J. Lipophilic yeasts in skin disease. Semin Dermatol 1985; 4: 173–184 Faergemann J. Lipophilic yeasts in skin disease. Semin Dermatol 1985; 4: 173–184
9.
go back to reference Faergemann J. Pityrosporum infections. In: Elewski B.E., editor. Cutaneous fungal infections. New York: Igaku-Shoin, 1992: 69–83 Faergemann J. Pityrosporum infections. In: Elewski B.E., editor. Cutaneous fungal infections. New York: Igaku-Shoin, 1992: 69–83
10.
go back to reference Faergemann J. Tinea versicolor (Pityriasis versicolor). In: Demis D.J., editor. Clinical Dermatology. Philadelphia: Lippincott-Raven, 1995: 1–9 Faergemann J. Tinea versicolor (Pityriasis versicolor). In: Demis D.J., editor. Clinical Dermatology. Philadelphia: Lippincott-Raven, 1995: 1–9
11.
go back to reference Faergemann J., Fredriksson T. Propylene glycol in the treatment of tinea versicolor. Acta Derm Venereol (Stockh) 1989; 60: 92–93 Faergemann J., Fredriksson T. Propylene glycol in the treatment of tinea versicolor. Acta Derm Venereol (Stockh) 1989; 60: 92–93
12.
go back to reference Fredriksson T. Topical treatment with BAY b 5097, a new broad spectrum antimycotic agent. Br J Dermatol 1972; 86: 628–630PubMedCrossRef Fredriksson T. Topical treatment with BAY b 5097, a new broad spectrum antimycotic agent. Br J Dermatol 1972; 86: 628–630PubMedCrossRef
13.
go back to reference Svejgaard E. Double-blind trial of miconazole in dermatomycosis. Acta Derma Venereol (Stockh) 1973; 53: 497–499 Svejgaard E. Double-blind trial of miconazole in dermatomycosis. Acta Derma Venereol (Stockh) 1973; 53: 497–499
14.
go back to reference Swartz K.J., Moch T.H., Kenzelmann M. Poloklinische Prüfung von Econazole bei 594 Fallen von Hautmykosen. Dtsch Med Wochenschr 1975; 100: 1497–1500CrossRef Swartz K.J., Moch T.H., Kenzelmann M. Poloklinische Prüfung von Econazole bei 594 Fallen von Hautmykosen. Dtsch Med Wochenschr 1975; 100: 1497–1500CrossRef
15.
go back to reference Faergemann J., Fredriksson T. An open trial of the effect of a zinc pyrithione shampoo in tinea versicolor. Cutis 1980; 25: 667–669PubMed Faergemann J., Fredriksson T. An open trial of the effect of a zinc pyrithione shampoo in tinea versicolor. Cutis 1980; 25: 667–669PubMed
16.
go back to reference Albright S.D., Hitch J.M. Rabbit treatment of tinea versicolor with selenium sulphide. Arch Dermatol 1966; 93: 460–461PubMedCrossRef Albright S.D., Hitch J.M. Rabbit treatment of tinea versicolor with selenium sulphide. Arch Dermatol 1966; 93: 460–461PubMedCrossRef
17.
go back to reference Hernandez-Perez E. A comparison between one and two week’s treatment with bifonazole in pityriasis versicolor. J Am Acad Dermatol 1986; 14: 561–564PubMedCrossRef Hernandez-Perez E. A comparison between one and two week’s treatment with bifonazole in pityriasis versicolor. J Am Acad Dermatol 1986; 14: 561–564PubMedCrossRef
18.
go back to reference Savin R.C., Horwitz S.N. Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol 1986; 15: 500–503PubMedCrossRef Savin R.C., Horwitz S.N. Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol 1986; 15: 500–503PubMedCrossRef
19.
go back to reference Aste N., Pau M., Pinna A.L., et al. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses 1991; 34: 353–357PubMedCrossRef Aste N., Pau M., Pinna A.L., et al. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses 1991; 34: 353–357PubMedCrossRef
20.
go back to reference Faergemann J., Hersle K., Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatol 1997; 194 Suppl. 1: 19–21CrossRef Faergemann J., Hersle K., Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatol 1997; 194 Suppl. 1: 19–21CrossRef
21.
go back to reference Vermeer B.J., Staats C.C.G. The efficacy of a topical application application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo controlled study. Dermatol 1997; 194 Suppl. 1: 22–24CrossRef Vermeer B.J., Staats C.C.G. The efficacy of a topical application application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo controlled study. Dermatol 1997; 194 Suppl. 1: 22–24CrossRef
22.
go back to reference Corte M., Jung K., Linker U., et al. Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor. Mycoses 1989; 32: 200–203PubMedCrossRef Corte M., Jung K., Linker U., et al. Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor. Mycoses 1989; 32: 200–203PubMedCrossRef
23.
go back to reference Rekacewicz I., Guillaume J.C., Benkhraba F., et al. A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor. Ann Dermatol Venereol 1990; 117: 709–711PubMed Rekacewicz I., Guillaume J.C., Benkhraba F., et al. A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor. Ann Dermatol Venereol 1990; 117: 709–711PubMed
24.
go back to reference Lange D.S., Richards H.M., Guarnieri J, et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo- controlled study. J Am Acad Dermatol 1998; 39: 944–950PubMedCrossRef Lange D.S., Richards H.M., Guarnieri J, et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo- controlled study. J Am Acad Dermatol 1998; 39: 944–950PubMedCrossRef
25.
go back to reference Jones H.E. Ketoconazole today. A review of clinical experience. Manchester, England: ADIS Press, 1987 Jones H.E. Ketoconazole today. A review of clinical experience. Manchester, England: ADIS Press, 1987
26.
go back to reference Faergemann J., Djärv L.: Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 1982; 30: 542–545PubMed Faergemann J., Djärv L.: Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 1982; 30: 542–545PubMed
27.
go back to reference Hay R.J., Midgley G. Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol 1984; 9: 571–573PubMedCrossRef Hay R.J., Midgley G. Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol 1984; 9: 571–573PubMedCrossRef
28.
go back to reference Rausch L.J., Jacobs P.H. Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. Cutis 1964; 34: 470–471 Rausch L.J., Jacobs P.H. Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. Cutis 1964; 34: 470–471
29.
go back to reference Shemer A., Nathansohn N., Kaplan B., et al. Itraconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat 1999; 10: 19–23CrossRef Shemer A., Nathansohn N., Kaplan B., et al. Itraconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat 1999; 10: 19–23CrossRef
30.
31.
go back to reference Faergemann J. Treatment of pityriasis versicolor with itraconazole. A doubleblind placebo-controlled study. Mykoses 1988; 31: 377–379CrossRef Faergemann J. Treatment of pityriasis versicolor with itraconazole. A doubleblind placebo-controlled study. Mykoses 1988; 31: 377–379CrossRef
32.
go back to reference Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol (Stockh) 1992; 72: 74–75 Faergemann J. Treatment of pityriasis versicolor with a single dose of fluconazole. Acta Derm Venereol (Stockh) 1992; 72: 74–75
33.
go back to reference Amer M.A. Fluconazole in the treatment of tinea versicolor. Int J Dermatol 1997; 36: 938–946CrossRef Amer M.A. Fluconazole in the treatment of tinea versicolor. Int J Dermatol 1997; 36: 938–946CrossRef
34.
go back to reference Burton J.L., Holden C.A. Seborrhoeic dermatitis. In: Champion R.H., Burton J.L., Burna D.A., et al., editors. Textbook of Dermatology (ed 6). Oxford: Blackwell Scientific Publications, 1998: pp 638–643 Burton J.L., Holden C.A. Seborrhoeic dermatitis. In: Champion R.H., Burton J.L., Burna D.A., et al., editors. Textbook of Dermatology (ed 6). Oxford: Blackwell Scientific Publications, 1998: pp 638–643
35.
go back to reference Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Dactacort), miconazole and hydrocrotisone. Br J Dermatol 1986; 114: 695–700PubMedCrossRef Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Dactacort), miconazole and hydrocrotisone. Br J Dermatol 1986; 114: 695–700PubMedCrossRef
36.
go back to reference Bergbrant I.-M. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Acta Derm Venereol Suppl (Stockh) 1991; 167: 1–36 Bergbrant I.-M. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Acta Derm Venereol Suppl (Stockh) 1991; 167: 1–36
37.
go back to reference Sohnle P.G., Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol 1983; 80: 93–97PubMedCrossRef Sohnle P.G., Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol 1983; 80: 93–97PubMedCrossRef
38.
go back to reference Midgley G., Hay R.J. Serological responses to Pityrosporum (Malassezia) in seborrhoeic dermatitis demonstrated by ELISA and Western blotting. Bull Soc Fr Mycol Méd 1988; 17: 267–276 Midgley G., Hay R.J. Serological responses to Pityrosporum (Malassezia) in seborrhoeic dermatitis demonstrated by ELISA and Western blotting. Bull Soc Fr Mycol Méd 1988; 17: 267–276
39.
go back to reference Neuber K., Kröger S., Gruseck E., et al. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN?) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch Dermatol Res 1996; 288: 532–536PubMed Neuber K., Kröger S., Gruseck E., et al. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN?) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch Dermatol Res 1996; 288: 532–536PubMed
40.
go back to reference Wikler J.R., Trago E., de Haan P., et al. Cell-mediated deficiency to Pityrosporum orbiculare in patients with seborrhoeic dermatitis [abstract]. ESDR-JSID-SID Tricontinental Meeting; 1989 Apr 26-30; Washington DC Wikler J.R., Trago E., de Haan P., et al. Cell-mediated deficiency to Pityrosporum orbiculare in patients with seborrhoeic dermatitis [abstract]. ESDR-JSID-SID Tricontinental Meeting; 1989 Apr 26-30; Washington DC
41.
go back to reference Ashbee H.R., Ingham E., Holland K.T, et al. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994; 3: 106–112PubMedCrossRef Ashbee H.R., Ingham E., Holland K.T, et al. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994; 3: 106–112PubMedCrossRef
42.
go back to reference Bergbrant I.-M., Andersson B., Faergemann J. Cell-mediated immunity to Pityrosporum ovale in patients with seborrhoeic dermatitis and pityriasis versicolor. Cin Exp Dermatol 1999; 24: 402–406CrossRef Bergbrant I.-M., Andersson B., Faergemann J. Cell-mediated immunity to Pityrosporum ovale in patients with seborrhoeic dermatitis and pityriasis versicolor. Cin Exp Dermatol 1999; 24: 402–406CrossRef
43.
go back to reference Pearry M.E., Sharpe G.R. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998; 139: 254–263CrossRef Pearry M.E., Sharpe G.R. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998; 139: 254–263CrossRef
44.
go back to reference Bergbrant I.-M., Johansson S., Robbins D., et al. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991; 16: 331–338PubMedCrossRef Bergbrant I.-M., Johansson S., Robbins D., et al. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991; 16: 331–338PubMedCrossRef
45.
go back to reference Kieffer M., Bergbrant I.-M., Faergemann J., et al. Skov patients with atopic dermatitis and seborrhoeic dermatitis. J Am Acad Dermatol 1990; 22: 739–742PubMedCrossRef Kieffer M., Bergbrant I.-M., Faergemann J., et al. Skov patients with atopic dermatitis and seborrhoeic dermatitis. J Am Acad Dermatol 1990; 22: 739–742PubMedCrossRef
46.
go back to reference Kesavan S., Walters C.E., Holland K.T, et al. The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blood mononuclear cells in vitro. Med Mycol 1998; 36: 97–106PubMed Kesavan S., Walters C.E., Holland K.T, et al. The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blood mononuclear cells in vitro. Med Mycol 1998; 36: 97–106PubMed
47.
go back to reference Piérard-Franshimont C., Arrese J.E., Piérard G.E. Immunohistochemical aspects of the link between Malassezia ovalis and seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1995; 4: 14–49CrossRef Piérard-Franshimont C., Arrese J.E., Piérard G.E. Immunohistochemical aspects of the link between Malassezia ovalis and seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1995; 4: 14–49CrossRef
48.
go back to reference Romani L., Bistoni F., Puccetti P. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem Immunol 1997; 68: 110–135PubMedCrossRef Romani L., Bistoni F., Puccetti P. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem Immunol 1997; 68: 110–135PubMedCrossRef
49.
go back to reference Gulay Z., Imir T. Anti-candidial activity of natural killer (NK) an lymphokine activated killer (LAK) lymphocytes in vitro. Immunobiol 1996; 95: 220–230CrossRef Gulay Z., Imir T. Anti-candidial activity of natural killer (NK) an lymphokine activated killer (LAK) lymphocytes in vitro. Immunobiol 1996; 95: 220–230CrossRef
50.
go back to reference Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235–242PubMedCrossRef Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235–242PubMedCrossRef
51.
go back to reference Skinner R.B., Noah P.W., Taylor R.M., et al. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 2: 852–857CrossRef Skinner R.B., Noah P.W., Taylor R.M., et al. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 2: 852–857CrossRef
52.
go back to reference Faergemann J. Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. Acta Dermato Venereol (Stockh) 1990; 70: 171–172 Faergemann J. Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. Acta Dermato Venereol (Stockh) 1990; 70: 171–172
53.
go back to reference Ford G.P., Farr P.M., Ive F.A., et al. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984; 111: 603–607PubMedCrossRef Ford G.P., Farr P.M., Ive F.A., et al. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984; 111: 603–607PubMedCrossRef
54.
go back to reference Stratigos I.D., Katamboas A., Antoniu C.H., et al. Ketoconazole 2% cream versus 1% hydrocortisone cream in the treatment of seborrhoeic dermatitis: a doubleblind comparative study. J Am Acad Dermatol 1988; 19: 850–853PubMedCrossRef Stratigos I.D., Katamboas A., Antoniu C.H., et al. Ketoconazole 2% cream versus 1% hydrocortisone cream in the treatment of seborrhoeic dermatitis: a doubleblind comparative study. J Am Acad Dermatol 1988; 19: 850–853PubMedCrossRef
55.
go back to reference Marks R., Pears A.D., Walker A.P. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985; 112: 415–422PubMedCrossRef Marks R., Pears A.D., Walker A.P. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985; 112: 415–422PubMedCrossRef
56.
go back to reference Faergemann J. Propylene glycol in the treatment of seborrheic dermatitis of the scalp: a double-blind study. Cutis 1988; 42: 69–71PubMed Faergemann J. Propylene glycol in the treatment of seborrheic dermatitis of the scalp: a double-blind study. Cutis 1988; 42: 69–71PubMed
57.
58.
go back to reference Shuttleworth D., Squire R.A., Boorman G.C., et al. Comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) or ketoconazole (2%; Nizoral) for the control of dandruff/seborrhoeic dermatitis. J Dermatol Treat 1998; 9: 157–162CrossRef Shuttleworth D., Squire R.A., Boorman G.C., et al. Comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) or ketoconazole (2%; Nizoral) for the control of dandruff/seborrhoeic dermatitis. J Dermatol Treat 1998; 9: 157–162CrossRef
59.
go back to reference Zeharia A., Mimouni M., Fogel D. Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Ped Dermatol 1996; 13: 151–153CrossRef Zeharia A., Mimouni M., Fogel D. Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Ped Dermatol 1996; 13: 151–153CrossRef
60.
go back to reference Pari T., Pulimood S., Jacob M., et al. Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1998; 10: 89–90PubMedCrossRef Pari T., Pulimood S., Jacob M., et al. Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis. J Eur Acad Dermatol Venereol 1998; 10: 89–90PubMedCrossRef
61.
go back to reference Veen A.J., Prevoo R.L.M.A., Velders A.J., et al. Betamethasone-17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults. J Dermatol Treat 1998; 9: 239–245CrossRef Veen A.J., Prevoo R.L.M.A., Velders A.J., et al. Betamethasone-17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults. J Dermatol Treat 1998; 9: 239–245CrossRef
Metadata
Title
Management of Seborrheic Dermatitis and Pityriasis Versicolor
Author
Dr Jan Faergemann
Publication date
01-03-2000
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 2/2000
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200001020-00001

Other articles of this Issue 2/2000

American Journal of Clinical Dermatology 2/2000 Go to the issue

Disease Management

Management of Hirsutism

Review Article

Alopecia Areata

Practical Dermatology

Diabetic Foot Ulcers

Practical Dermatology

Diagnosing Superficial Mycoses